From: HRG C633T polymorphism and risk of gestational hypertensive disorders: a pilot study
Cases | Controls | ||
---|---|---|---|
Maternal age, yrs | 32 (IQR = 7) | 31 (IQR = 7) | p = 0.012 |
Maternal BMI, kg/m2 | 25.97 (IQR = 6.52) | 23.55 (IQR = 5.18) | p < 0.001 |
Primiparity | 50/92 (54.3%) | 89/200 (44.5%) | p = 0.118 |
Nicotine use | 9/89 (10.1%) | 13/196 (6.6%) | p = 0.308 |
Homozygous C/C | 36/92 (48.3%) | 105/200 (52.5%) | p = 0.034 |
Heterozygous C/T | 42/92 (39.7%) | 74/200 (37%) | p = 0.180 |
Homozygous T/T | 14/92 (12%) | 21/200 (10.5%) | p = 0.249 |
Gestational length, weeks | 39 (IQR = 2) | 40 (IQR = 1) | p = 0.014 |
Male Infant Gender | 50/91 (54.9%) | 108/199 (54.3%) | p = 0.915 |
Birthweight, gr | 3410 (IQR 896) | 3680 (IQR658) | p = 0.001 |
Birthlength, cm | 50 (IQR 4) | 51 (IQR 3) | p = 0.014 |